Williams Lewis T
Director at PTGX; President, CEO and Chairman at FIVE PRIME THERAPEUTICS INC
- Sold, on record
- $16.5M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Feb 17, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- PTGXProtagonist Therapeutics, IncDirector
- FIVE PRIME THERAPEUTICS INCPresident, CEO and Chairman
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- FIVE PRIME THERAPEUTICS INC453,349 shares
- PTGX18,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedMar 30, 2016 2016
Sold 23,259 shares at $40.02 ($931k)
Williams Lewis T, President, CEO and Chairman
Sold 6.4% of holdings ($14.6M position)340,528 shares left0.7x usual sizeFiling
- 2 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedApr 6, 2016 +7 days
Sold 52,801 shares at $43.09 ($2.3M)
Williams Lewis T, President, CEO and Chairman
Sold 13.4% of holdings ($16.9M position)340,528 shares left1.9x usual sizeFiling
- 3 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedApr 14, 2016 +8 days
Sold 2,725 shares at $48.00 ($131k)
Williams Lewis T, President, CEO and Chairman
Sold 0.8% of holdings ($16.5M position)340,528 shares left0.1x usual sizeFiling
- 4 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedApr 15, 2016 +1 day
Sold 1,405 shares at $48.00 ($67k)
Williams Lewis T, President, CEO and Chairman
Sold 0.4% of holdings ($16.4M position)340,528 shares left0.1x usual sizeFiling
- 5 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedApr 21, 2016 +6 days
Sold 48,671 shares at $48.05 ($2.3M)
Williams Lewis T, President, CEO and Chairman
Sold 12.5% of holdings ($18.7M position)340,528 shares left2.1x usual sizeFiling
- 6 Form 4 sale FIVE PRIME THERAPEUTICS INCPlan not statedDec 23, 2016 +246 days
Sold 30,000 shares at $50.50 ($1.5M)
Williams Lewis T, President, CEO and Chairman
Sold 6.5% of holdings ($23.4M position)433,892 shares left0.8x usual sizeFiling
- 7 Form 144 notice PTGXNoticeFeb 17, 2026 +3343 days
Filed to sell 18,000 shares ($1.5M)
Williams Lewis T, Director
No 10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale PTGXUnusualFeb 17, 2026 same day
Sold 18,000 shares at $82.42 ($1.5M)
Williams Lewis T, Director
No 10b5-1 planSold 69.7% of holdings ($2.1M position)7,825 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 18, 2026 | PTGX | Director | Form 4 sale | 18,000 | $1.5M | 69.7% | Unusual | SEC |
| Feb 17, 2026 | Feb 17, 2026 | PTGX | Director | Form 144 notice | 18,000 | $1.5M | Notice | SEC | |
| Dec 23, 2016 | Dec 23, 2016 | FIVE PRIME THERAPEUTICS INC | President, CEO and Chairman | Form 4 sale | 30,000 | $1.5M | 6.5% | Plan not stated | SEC |
| Apr 21, 2016 | Apr 22, 2016 | FIVE PRIME THERAPEUTICS INC | President, CEO and Chairman | Form 4 sale | 48,671 | $2.3M | 12.5% | Plan not stated | SEC |
| Apr 15, 2016 | Apr 18, 2016 | FIVE PRIME THERAPEUTICS INC | President, CEO and Chairman | Form 4 sale | 1,405 | $67k | 0.4% | Plan not stated | SEC |
| Apr 14, 2016 | Apr 15, 2016 | FIVE PRIME THERAPEUTICS INC | President, CEO and Chairman | Form 4 sale | 2,725 | $131k | 0.8% | Plan not stated | SEC |
| Apr 6, 2016 | Apr 7, 2016 | FIVE PRIME THERAPEUTICS INC | President, CEO and Chairman | Form 4 sale | 52,801 | $2.3M | 13.4% | Plan not stated | SEC |
| Mar 30, 2016 | Mar 31, 2016 | FIVE PRIME THERAPEUTICS INC | President, CEO and Chairman | Form 4 sale | 23,259 | $931k | 6.4% | Plan not stated | SEC |
| Mar 2, 2016 | Mar 3, 2016 | FIVE PRIME THERAPEUTICS INC | President and CEO | Form 4 sale | 23,259 | $838k | 6.4% | Plan not stated | SEC |
| Feb 4, 2016 | Feb 8, 2016 | FIVE PRIME THERAPEUTICS INC | President and CEO | Form 4 sale | 71,229 | $2.4M | 17.3% | Plan not stated | SEC |
| Oct 15, 2015 | Oct 19, 2015 | FIVE PRIME THERAPEUTICS INC | President and CEO | Form 4 sale | 72,352 | $2M | 19.7% | Plan not stated | SEC |
| Sep 21, 2015 | Sep 23, 2015 | FIVE PRIME THERAPEUTICS INC | President and CEO | Form 4 sale | 2,648 | $58k | 0.7% | Plan not stated | SEC |
| Jun 22, 2015 | Jun 24, 2015 | FIVE PRIME THERAPEUTICS INC | President and CEO | Form 4 sale | 75,000 | $1.9M | 20.3% | Plan not stated | SEC |
| Nov 4, 2014 | Nov 4, 2014 | FIVE PRIME THERAPEUTICS INC | President and CEO | Form 4 sale | 32,603 | $426k | 8.4% | Plan not stated | SEC |
| Oct 30, 2014 | Oct 30, 2014 | FIVE PRIME THERAPEUTICS INC | President and CEO | Form 4 sale | 17,397 | $228k | 4.3% | Plan not stated | SEC |